Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02594644 · ClinicalTrials.gov registry record · NA

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT02594644: Completed NA study, sponsored by University of California, Davis.

NCT02594644 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02594644, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

Primary Outcome

The primary endpoint will be the difference in the percentage of complete clearance of the actinic keratoses as an intraindividual comparison between the treatment groups.

Interventions

  • DRUG Aminolevulinic Acid
  • DEVICE Microneedle Roller
  • RADIATION Blue Light

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2014-11-06
Est. Completion 2016-06-22
Phase NA
University of California, Davis

657 total trials

What the finished NCT02594644 record still lists

NCT02594644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Aminolevulinic Acid is the first listed.

NCT02594644 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02594644 about?

NCT02594644 is a clinical study titled "The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy". The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

What is the current status of trial NCT02594644?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-11-06. Estimated completion is 2016-06-22.

What interventions are being tested in trial NCT02594644?

The interventions under investigation include: Aminolevulinic Acid (DRUG), Microneedle Roller (DEVICE), Blue Light (RADIATION).

Who is sponsoring clinical trial NCT02594644?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02594644's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02594644, the US trial registry maintained by the National Library of Medicine. NCT02594644 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.